Ethical considerations in nanomedicine research involving women
clinical trials; ethical considerations; gender; Nanomedicine; women
This chapter elaborates social impact and perspectives of advanced technologies as well as critically discuss the ethical issues of womens participation in nano-medicine research. It starts by addressing the issue that women have been under sampled in clinical research but it is moral to take their samples farther into research most notably with certain special health conditions and unique reactions to drug treatments that are likely to be unique to women. One of the most emphasized concepts is informed consent, for the purpose of precisions and clarity in explaining its purpose and usefulness, as well as the probable consequences in the form of some narrowly speculative treatments with particular relevance to certain probabilities remaining beyond the range of perception on the female body after some or other nano-scale procedures. The chapter also talks about the ethical implications in the present strategies to increase the efficacy and safety for women only therapies like nanomedicine; the author urges for stringent preclinical and clinical guidelines which should have examined the following gender variations. It also examines the regulation with guidance and suggests contingency structures that are employed in the management of the ethical use of nanomedicine in women health care. Therefore this chapter tries to develop ethics together with science, incorporate these met ethical considerations into methods and guidelines in research, to contribute to enhancement of beneficial impact of the nanomedicine for womens rights and well-being. 2026 Elsevier Inc. All rights reserved..
Shakya, Richa; Srivastava, Shivam; Paul Richards, M.; Agrawal, Ankur; Saharan, Renu; Bhise, Manish R.; Suresh, Venkata; Anjali, P.K.
Nanomedicine Advancements and Intersectional Perspectives for Women's Health;pp.237-263
Restricted Access; Hardcopy may be available in the library
https://doi.org/10.1016/B978-0-443-33056-8.00005-1 https://www.scopus.com/pages/publications/105026848032?origin=resultslist
Shakya R., Department of Pharmacy, Faculty of Pharmaceutical Sciences, Rama University, Uttar Pradesh, Kanpur, India; Srivastava S., Truba College of Pharmacy, Madhya Pradesh, Bhopal, India; Paul Richards M., Aditya Bangalore Institute of Pharmacy Education and Research, Affiliated to Rguhs, Karnataka, Bangalore, India; Agrawal A., Department of Pharmacy, Jai Institute of Pharmaceutical Sciences and Research, Madhya Pradesh, Gwalior, India; Saharan R., Department of Pharmacy, M. M. College of Pharmacy, MMDU, Haryana, Ambala, India; Bhise M.R., Department of Pharmaceutics, SGSPS, Institute of Pharmacy, Affiliated to Sant Gadge Baba Amravati University, Maharashtra, Amravati, India; Suresh V., Department of Pharmacy, Vathsalya College of Pharmacy, Telangana, Bhuvanagiri, India; Anjali P.K., Department of Economics, CHRIST (Deemed to be University), Karnataka, Bangalore, India